Partnership between Pharma and Patients
Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients. Read More...
Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology. Read More...
A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.
Engaging patients for drug repurposing: Mapping the patient engagement continuum
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.
Patient Research Priorities
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Patient Engagment/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Listening to Patients
In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Continuing Reading More Innovation News and Blogs...